Divi's Laboratories Limited (BOM:532488)

India flag India · Delayed Price · Currency is INR
5,638.35
-119.15 (-2.07%)
At close: Apr 17, 2025
49.57%
Market Cap 1.65T
Revenue (ttm) 90.78B
Net Income (ttm) 20.67B
Shares Out n/a
EPS (ttm) 77.84
PE Ratio 79.83
Forward PE n/a
Dividend 30.00 (0.53%)
Ex-Dividend Date Aug 2, 2024
Volume 20,847
Average Volume 23,336
Open 5,757.45
Previous Close 5,757.50
Day's Range 5,592.70 - 5,795.75
52-Week Range 3,640.10 - 6,448.75
Beta n/a
RSI 66.00
Earnings Date May 23, 2025

About Divi's Laboratories

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It al... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1990
Employees 9,741
Stock Exchange Bombay Stock Exchange
Ticker Symbol 532488
Full Company Profile

Financial Performance

In 2023, Divi's Laboratories's revenue was 78.45 billion, an increase of 1.00% compared to the previous year's 77.67 billion. Earnings were 16.00 billion, a decrease of -12.28%.

Financial Statements

News

There is no news available yet.